Rapport Therapeutics

About:

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Website: https://www.rapportrx.com

Top Investors: ARCH Venture Partners, Cormorant Asset Management, Fidelity, Perceptive Advisors, Sofinnova Investments

Description:

Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding, communication, teamwork, and trust.

Total Funding Amount:

$250M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2022-01-01

Founders:

David Bredt, Steven Paul

Number of Employees:

11-50

Last Funding Date:

2023-08-23

IPO Status:

Public

Industries:

© 2025 bioDAO.ai